Table of contents
As your pharmaceutical company builds and deploys serialization and track and trace capabilities to support the EU Falsified Medicines Directive (EU FMD), the challenge of managing all your requirements and specifications will become more and more complex. And time-consuming.
To help you prepare, we
Learn:
- How frontrunners across Germany, Spain, Scandinavia, and Italy are addressing EU FMD.
- What the biggest roadblocks are right now.
- What makes implementing Level 1-Level 5 so complex.
- How you can improve compliance outcomes as
the February 9, 2019, deadline gets closer.
If you have additional questions, we invite you to marketing [at] tracelink.com (Subject: EU%20FMD%20Questions) (contact us) and speak with a serialization expert.
